Format

Send to

Choose Destination
Arch Dis Child. 2012 Mar;97(3):221-6. doi: 10.1136/archdischild-2011-300564. Epub 2012 Jan 13.

Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis.

Author information

1
Health Economics Unit, School of Health and Populations Science, University of Birmingham, Birmingham, UK. t.e.roberts@bham.ac.uk

Abstract

OBJECTIVE:

To undertake a cost-effectiveness analysis that compares pulse oximetry as an adjunct to clinical examination with clinical examination alone in newborn screening for congenital heart defects (CHDs).

DESIGN:

Model-based economic evaluation using accuracy and cost data from a primary study supplemented from published sources taking an NHS perspective.

SETTING:

Six large maternity units in the UK.

PATIENTS:

20 055 newborn infants prior to discharge from hospital.

INTERVENTION:

Pulse oximetry as an adjunct to clinical examination.

MAIN OUTCOME MEASURE:

Cost effectiveness based on incremental cost per timely diagnosis.

RESULTS:

Pulse oximetry as an adjunct to clinical examination is twice as costly but provides a timely diagnosis to almost 30 additional cases of CHD per 100 000 live births compared with a modelled strategy of clinical examination alone. The incremental cost-effectiveness ratio for this strategy compared with clinical examination alone is approximately £24 000 per case of timely diagnosis in a population in which antenatal screening for CHDs already exists. The probabilistic sensitivity analysis suggests that at a willingness-to-pay (WTP) threshold of £100 000, the probability of 'pulse oximetry as an adjunct to clinical examination' being cost effective is more than 90%. Such a WTP threshold is plausible if a newborn with timely diagnosis of a CHD gained just five quality-adjusted life years, even when treatment costs are taken into consideration.

CONCLUSION:

Pulse oximetry as an adjunct to current routine practice of clinical examination alone is likely to be considered a cost-effective strategy in the light of currently accepted thresholds.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center